Article
Genetic Predisposition to Glioma Mediated by a MAPKAP1 Enhancer Variant.
Cellular and molecular neurobiology - 1 May 2020
Huang Liming, Xu Wenshen, Yan Danfang, You Xin, Shi Xi, Zhang Shu, Hong Hualan, Dai Lian
Abstract excerpt
Mitogen-activated protein kinase-associated protein 1 (MAPKAP1) is a unique component of the mechanistic target of rapamycin (MTOR) pathway which plays a pivotal role in carcinogenesis. The role of enhancer variant in carcinogenesis receives increased attentions. However, the significance of enhancer variants of MAPKAP1 in glioma has not yet been investigated. The associations of enhancer variants of MAPKAP1 with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
